Amneal Pharmaceuticals, Inc.
Hedge Funds Holdings
Last updated:
Amneal Pharmaceuticals, Inc.‘s stocks are currently a part of 89 hedge funds’ portfolios, which represents 31.05% of the total amount of its stocks outstanding. This makes up a total of 46.86M shares of Amneal Pharmaceuticals, Inc.. Compared to the previous quarter, the number fell by -53.97% or -54.94M shares fewer. As for the holding position changes, 28.09% (25) of current hedge fund investors increased the number of shares held, 34.83% (31) of current holders sold a part of the shares held, and 11.24% (10) closed the holdings completely. 5 hedge funds are new holders of Amneal Pharmaceuticals, Inc. stock in Q1 2023, it is 5.62% of total holders.
Hedge funds holding Amneal Pharmaceuticals (Q2 2018 – Q1 2023)
| Q2 2018 | 164 |
|---|---|
| Q3 2018 | 165 |
| Q4 2018 | 165 |
| Q1 2019 | 159 |
| Q2 2019 | 121 |
| Q3 2019 | 113 |
| Q4 2019 | 120 |
| Q1 2020 | 120 |
| Q2 2020 | 133 |
| Q3 2020 | 134 |
| Q4 2020 | 129 |
| Q1 2021 | 158 |
| Q2 2021 | 155 |
| Q3 2021 | 152 |
| Q4 2021 | 150 |
| Q1 2022 | 158 |
| Q2 2022 | 146 |
| Q3 2022 | 147 |
| Q4 2022 | 154 |
| Q1 2023 | 89 |
Hedge funds changes in Amneal Pharmaceuticals positions (Q2 2018 – Q1 2023)
| Q2 2018 | 164 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q3 2018 | 37 | 57 | 45 | 36 | -10 |
| Q4 2018 | 25 | 44 | 71 | 23 | 2 |
| Q1 2019 | 17 | 60 | 46 | 23 | 13 |
| Q2 2019 | 23 | 42 | 37 | 59 | -40 |
| Q3 2019 | 23 | 44 | 29 | 31 | -14 |
| Q4 2019 | 25 | 50 | 32 | 16 | -3 |
| Q1 2020 | 28 | 38 | 36 | 26 | -8 |
| Q2 2020 | 32 | 32 | 51 | 18 | 0 |
| Q3 2020 | 18 | 39 | 48 | 16 | 13 |
| Q4 2020 | 21 | 38 | 43 | 26 | 1 |
| Q1 2021 | 48 | 41 | 46 | 17 | 6 |
| Q2 2021 | 24 | 53 | 50 | 27 | 1 |
| Q3 2021 | 17 | 46 | 50 | 19 | 20 |
| Q4 2021 | 18 | 45 | 54 | 17 | 16 |
| Q1 2022 | 19 | 55 | 54 | 10 | 20 |
| Q2 2022 | 14 | 48 | 48 | 20 | 16 |
| Q3 2022 | 26 | 39 | 48 | 25 | 9 |
| Q4 2022 | 31 | 49 | 45 | 25 | 4 |
| Q1 2023 | 5 | 25 | 31 | 10 | 18 |
Hedge funds changes in Amneal Pharmaceuticals stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 336,000 | 1,060,000 |
|---|---|---|
| Q3 2018 | 1,466,000 | 1,222,000 |
| Q4 2018 | 1,588,000 | 41,000 |
| Q1 2019 | 1,311,000 | 213,000 |
| Q2 2019 | 875,000 | 476,000 |
| Q3 2019 | 67,000 | 966,000 |
| Q4 2019 | 75,000 | 850,000 |
| Q1 2020 | 305,000 | 574,000 |
| Q2 2020 | 1,742,000 | 1,033,000 |
| Q3 2020 | 1,332,000 | 581,000 |
| Q4 2020 | 1,930,000 | 1,077,000 |
| Q1 2021 | 2,404,000 | 2,537,000 |
| Q2 2021 | 1,568,000 | 1,658,000 |
| Q3 2021 | 2,376,000 | 2,364,000 |
| Q4 2021 | 1,411,000 | 3,875,000 |
| Q1 2022 | 742,000 | 3,566,000 |
| Q2 2022 | 547,000 | 2,487,000 |
| Q3 2022 | 393,000 | 1,079,000 |
| Q4 2022 | 118,709 | 149,449 |
| Q1 2023 | 9,000 | 1,000 |